Cholesterol-Lowering Drugs Are a Giant Hoax


What we now observe is a blistering condemnation of cholesterol-lowering statin drugs coming out of news sources in Great Britain with absolute silence on the subject from US-based news agencies.

The scathing denunciation of statin drugs emanates from The Pharmaceutical Journal in the UK that declares the cholesterol hypothesis of cardiovascular disease is “dead.”

The prevalent mantra that statins are “life-savers” and that “people will die” if they discontinue statins, as well as advice “everyone over 50 should be on a statin drug,” is based upon “cherry-picking” of the data say investigators.  A review of 44 published trials of statin drugs finds among subjects taking statins to prevent heart attacks, these pills only add 4 days to one’s life!

Buy Gold at Discounted Prices

Even the newly introduced evolocumab (Repatha), which is an injected drug that reduces circulating cholesterol by a whopping 60% only reduced the incidence of non-fatal heart attacks by 1.5%.

Hoax on humanity

The revelation that Big Pharma and its minions of medical journal editors and medical journalists have pulled off a giant hoax on humanity is an example of the growing realization of a cabal that continues to perpetrate medical falsehoods under the guise of science.

French researchers conclude it is possible “nobody benefits from statins.”

The Cochrane global network of researchers who analyze the risks and benefits of medicines calls for a “do not resuscitate” order on cholesterol as the cause of heart disease.”  This means, bury the cholesterol paradigm now and forever.  But again, this clarion call is coming from British-based news press.

Don’t expect a U turn anytime soon

Certainly such a ruse represents a whopper of a lie.  About a quarter of Americans over 45 years of age take statins as pharmaceutical companies rake in billions of dollars in sales.

Will any of the recent revelations about statin drugs change the course of modern medicine?  Will guidelines for medical care of patients who have experienced heart attacks and

You can read the rest of this article at: